Academic Seminars

Kristen Edwards, Ph.D. to present seminar on 11/11/22 at 11:00 AM, LIB-110: “Sex-specific effects of indomethacin-induced inflammatory bowel disease on mitochondrial function”.
November 11, 2022
 

Kristen Edwards, Ph.D.
Assistant Professor, Department of Cell & Molecular Biology
University of Mississippi Medical Center

“Sex-specific effects of indomethacin-induced inflammatory bowel disease on mitochondrial function”

Inflammatory bowel disease (IBD) characterized by inflammation of the gastrointestinal tract. In 2015, 3 million U.S. adults have been diagnosed with IBD and many people go undiagnosed due to mild symptoms. Women appear to have more severe and recurring symptoms of IBD compared to men, most likely due to hormonal fluctuations. Several studies show mitochondrial alterations in IBD patients. Our hypothesis is mitochondrial dysfunction in IBD could have a sex-specific effect. Male and female rats received two doses of indomethacin (7.5 mg/kg) 24 hour apart to induce IBD. Males showed no significant difference compared to controls with complex I and complex II-driven respiration. However, IBD females showed a significant decrease in Complex I-driven respiration and Complex II-driven respiration. For LCFA oxidation, males and females showed a significant increase in activity compared to controls. Both males and females showed no significant decrease MCFA oxidation. Males and females showed a significant increase in mtROS with all substrates. Complex IV activity was not different than controls in males but female activity was significantly decreased. Alterations to mitochondrial function and mitochondrial content observed in the indomethacin-induced IBD rat model suggests a link between mitochondrial dysfunction and IBD. There are differences in male and female rats suggesting a potential mechanism for the observed differences in male and female patients. Our study provides a better understanding of the role mitochondria in the development of IBD. It also opens an avenue for the development of strategies to re-establish normal mitochondrial function that could provide more options for preventive and therapeutic interventions for IBD.

Friday, November 11, 2022, 11:00AM-12:00PM, LIB-110
University of North Texas Health Science Center
Fort Worth, Texas